Yüklüyor......
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
BACKGROUND: The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V(2)-receptor antagonists inhibit cyst growth and slow the decline of kidney function. METHODS: In this phase...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3760207/ https://ncbi.nlm.nih.gov/pubmed/23121377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1205511 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|